1. Home
  2. OLN vs RCUS Comparison

OLN vs RCUS Comparison

Compare OLN & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Olin Corporation

OLN

Olin Corporation

HOLD

Current Price

$20.70

Market Cap

2.7B

Sector

Industrials

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$21.02

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLN
RCUS
Founded
1892
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.8B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
OLN
RCUS
Price
$20.70
$21.02
Analyst Decision
Hold
Buy
Analyst Count
14
9
Target Price
$23.93
$28.89
AVG Volume (30 Days)
3.4M
1.3M
Earning Date
01-29-2026
02-24-2026
Dividend Yield
3.84%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,780,800,000.00
$240,000,000.00
Revenue This Year
$2.92
N/A
Revenue Next Year
$1.26
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.68
N/A
52 Week Low
$17.66
$6.50
52 Week High
$32.88
$26.40

Technical Indicators

Market Signals
Indicator
OLN
RCUS
Relative Strength Index (RSI) 39.10 43.08
Support Level $22.29 $21.82
Resistance Level $24.79 $23.50
Average True Range (ATR) 1.11 1.27
MACD -0.30 -0.12
Stochastic Oscillator 20.98 10.63

Price Performance

Historical Comparison
OLN
RCUS

About OLN Olin Corporation

Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: